William Guyer, Chief Development Officer: Corcept Therapeutics CORT Sell · Filed 03/24

Trade details

Type: Insider sale
Amount: $423,729.67
Shares · price: 11,767 sh · $36.01 a share
Held after: 2,231 sh
Stock: Corcept Therapeutics CORT
Person: William GuyerChief Development Officer
Trade date: 26/03/20
Filed: 26/03/24
Days to filing: 4 days

Sold 84.1% of holdings

Share of holding sold: 84.1%

Corcept Therapeutics trades, last 26 weeks

What else happened in Corcept Therapeutics around then

Filed or reported within 30 days of the trade day · 02/18~04/19

William Guyer's recent trades

William GuyerChief Development Officer
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$2.3M
20,000 sh
$2.3M
Filed 08/04
Traded 08/04
William GuyerChief Development Officer
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$1.9M
20,000 sh
$1.9M
Filed 07/07
Traded 07/07
William GuyerChief Development Officer
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$1.4M
20,000 sh
$1.4M
Filed 06/04
Traded 06/02
William GuyerChief Development Officer
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$1.4M
20,000 sh
$1.4M
Filed 06/02
Traded 06/02
William GuyerChief Development Officer
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$1M
20,000 sh
$1M
Filed 05/07
Traded 05/05